ABOUT

Ethypharm‌ ‌is a‌ ‌leading‌ ‌specialty‌ ‌pharmaceutical‌ ‌company‌ ‌with‌ ‌a‌ ‌strong‌ ‌heritage,‌ ‌based‌ ‌in‌ ‌the‌ ‌UK.‌ ‌

Ethypharm‌ ‌acquired‌ ‌Martindale‌ ‌Pharma‌ ‌in‌ ‌January‌ ‌2017‌ creating‌ ‌its‌ ‌position‌ ‌as‌ ‌a‌ ‌leading‌ ‌UK-based‌ ‌specialty‌ pharmaceutical‌ ‌company‌ ‌providing‌ ‌value‌ ‌adding‌ pharmaceutical‌ ‌products‌ ‌to‌ ‌over‌ ‌80‌ ‌countries‌ ‌around‌ ‌the‌ ‌world.‌ ‌

We‌ ‌have‌ ‌developed‌ ‌a‌ ‌comprehensive‌ ‌range‌ ‌of‌ ‌medicines‌ ‌to‌ ‌support‌ ‌an‌ ‌individual’s‌ ‌recovery‌ ‌from‌ ‌opioid‌ ‌addiction.‌ ‌Our‌ ‌products‌ ‌include‌ ‌formulations‌ ‌of‌ ‌the‌ ‌three‌ ‌standard‌ ‌molecules‌ ‌in‌ ‌this‌ ‌therapy‌ ‌area;‌ ‌methadone,‌ ‌buprenorphine‌ ‌and‌ ‌naloxone.‌ ‌

It‌ ‌is‌ ‌this‌ ‌depth‌ ‌of‌ ‌expertise‌ ‌that‌ ‌makes‌ ‌us‌ ‌a‌ ‌market‌ ‌leader‌ ‌and‌ ‌a‌ ‌trusted‌ ‌supplier‌ ‌of‌ ‌opioid‌ ‌addiction‌ ‌products.‌

If you would like to discuss how our budget impact model can help manage your prescribing costs please email info@ethypharm.com or for further information on our products visit www.ethypharm.co.uk

​

UK-GP-22

Date of preparation:  August 2020